Cannabinoid Encyclopedia

Health and effects

Cannabinoids and NREM-2 sleep

What studies can tell us about cannabinoids and NREM-2 sleep, including human research, early evidence, and important limits.

Updated July 2026 2 research sources Human research included

The short answer

What does the research say about NREM-2 sleep?

Researchers have studied cannabinoids in connection with NREM-2 sleep. The current literature covers CBD, THC, and CBN. This page brings together 2 human-study sources. It includes 3 specific study findings from 2 sources. Human research is included, although its design and scope vary. There is no single answer that applies to every cannabinoid, dose, product, or person. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about NREM-2 sleep.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on NREM-2 sleep covers CBD, THC, and CBN; those areas should not be combined into one claim. 1

  2. 2

    Human research is included, although its design and scope vary. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 1

Research areas

What researchers studied about NREM-2 sleep

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Human research included

CBD

Researchers have studied CBD in connection with NREM-2 sleep. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 1

Human research included

THC

Researchers have studied THC in connection with NREM-2 sleep. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 1

Human research included

CBN

Researchers have studied CBN in connection with NREM-2 sleep. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 2

Results extracted so far

What did the studies report?

These summaries appear only when the recorded study outcome is specific enough to reproduce from the linked source. If a source has no result summary here, the result has not been extracted yet; that does not mean the study found no effect.

clinical study in people

Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial.

2 recorded findings

PubMed 40631525

  • In a randomized placebo-controlled crossover pilot trial involving 20 adults with DSM-5 insomnia disorder, researchers reported a decrease in total sleep time after an acute THC-CBD dose following 10 mg THC and 200 mg CBD once by the oral route over single study night. The recorded comparator was placebo. 1

    Recorded result: Total sleep time decreased by 24.5 minutes (P=.05; d=-.5).

  • In a randomized placebo-controlled crossover pilot trial involving 20 adults with DSM-5 insomnia disorder, researchers did not detect a difference in subjective sleep quality after an acute thc-cbd dose following 10 mg THC and 200 mg CBD once by the oral route over single study night. The recorded comparator was placebo. 1

    Recorded result: No change in subjective sleep quality was detected.

clinical study in people

Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial

1 recorded finding

PubMed 41698831

  • In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported more NREM-2 sleep following 300 mg CBN. The recorded comparator was placebo. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

2 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

Not prominent

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

Not prominent

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on NREM-2 sleep is not one kind of study. This source set includes 2 clinical studies in people. 1

The recorded populations or models include 20 adults with DSM-5 insomnia disorder (1 source), 20 adults with physician-diagnosed insomnia disorder (1 source), and people or patients (1 source). A result from one group or model should not be assumed to apply to another. 2

The most common recorded outcome focus is high-density EEG total sleep time (1 source), polysomnography NREM-2 sleep (1 source), and sleep-related outcomes (1 source). Closely related outcome names can still describe different measurements. 1

Some source records specify doses including 10 mg THC and 200 mg CBD once (1 source) and 300 mg CBN (1 source). These are descriptions of what researchers tested, not personal dosing instructions. 2

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

clinical study in people

Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial.

On this page, this source examines CBD and sleep, THC and sleep, and CBD and total sleep time after an acute THC-CBD dose and other related questions. 1

Study type
clinical study in people
Population or model
people or patients and 20 adults with DSM-5 insomnia disorder
Outcome focus
sleep-related outcomes and high-density EEG total sleep time and other recorded details
Dose recorded
10 mg THC and 200 mg CBD once
Evidence stage
human research

clinical study in people

Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial

On this page, this source examines CBN and nREM-2 sleep. 2

Study type
clinical study in people
Population or model
20 adults with physician-diagnosed insomnia disorder
Outcome focus
polysomnography NREM-2 sleep
Dose recorded
300 mg CBN
Evidence stage
human research

Safety and limits

What should readers keep in mind?

Research on NREM-2 sleep should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

Can cannabinoids help with NREM-2 sleep?

Research exists, but there is not one answer for every cannabinoid or product. Human research is included, although its design and scope vary. 1

Why can studies reach different answers?

Studies may test different cannabinoids, doses, formulations, routes, people, and outcomes. Those differences can change the result. 2

What should I check in a study?

Check whether it studied people, what product and dose it used, what it measured, how long it lasted, and whether safety was reported. 1

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research PubMed 40631525 DOI 10.1111/jsr.70124
  2. 2
    Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research PubMed 41698831 DOI 10.1111/jsr.70284
See all 2 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research / 1 linked research note PubMed 41698831
  2. Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research / 4 linked research notes PubMed 40631525